# Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection

> **NCT07672496** · NA · NOT_YET_RECRUITING · sponsor: **Fujian Medical University Union Hospital** · enrollment: 165 (estimated)

## Conditions studied

- Complicated Intra-abdominal Infection (cIAI)
- Systemic Inflammatory Response
- Sepsis
- Immune Dysfunction

## Interventions

- **DRUG:** ulinastatin
- **DRUG:** Normal Saline (0.9% NaCl)

## Key facts

- **NCT ID:** NCT07672496
- **Lead sponsor:** Fujian Medical University Union Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-30
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07672496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07672496, "Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07672496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*